4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial
John K. Forrest(Yale University), Michael J. Reardon(Houston Methodist), Hemal Gada(University of Pittsburgh Medical Center), G. Michael Deeb(Michigan Medicine), Tanvir Bajwa(Aurora Health Care), Didier Tchétché(Clinique Pasteur), Jian Huang(Guangxi Medical University), Mubashir Mumtaz(University of Pittsburgh Medical Center), Steven J. Yakubov(OhioHealth), Paul S. Teirstein(Scripps Health), Basel Ramlawi
Cited by 200
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k
Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2008|832